-
NBRVF Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Nabriva Therapeutics (NBRVF)
Company Profile
Quarter (USD) | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 2.26 mm | 2.26 mm | 2.26 mm | 2.26 mm | 2.26 mm | 2.26 mm |
Cash burn (monthly) | (no burn) | 1.49 mm | 4.02 mm | 4.54 mm | (no burn) | 1.08 mm |
Cash used (since last report) | n/a | 28.38 mm | 76.45 mm | 86.25 mm | n/a | 20.46 mm |
Cash remaining | n/a | -26.12 mm | -74.20 mm | -84.00 mm | n/a | -18.20 mm |
Runway (months of cash) | n/a | -17.5 | -18.5 | -18.5 | n/a | -16.9 |
13F holders | Current |
---|---|
Total holders | 5 |
Opened positions | 1 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 19.95 mm |
Total shares | 15.40 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Vivo Capital VIII | 4.80 mm | $7.01 mm |
Lincoln Park Capital Fund | 4.51 mm | $4.65 mm |
Longitude Capital Partners II | 4.26 mm | $5.62 mm |
HBM Healthcare Investments | 1.83 mm | $2.68 mm |
Proequities | 0.00 | $0.00 |